Pulmonary arterial hypertension is a serious condition where blood vessels in the lungs become narrowed and stiff, forcing the heart to work much harder to pump blood through them. While there is no cure, a range of treatments can help manage symptoms, slow disease progression, and improve quality of life. Understanding your options—from standard medications to promising therapies being tested in clinical trials—can help you work with your healthcare team to find the best approach for your situation.

How Treatment Helps You Live Better with Pulmonary Arterial Hypertension

When you receive a diagnosis of pulmonary arterial hypertension, or PAH, the main goal of treatment is to ease the burden this condition places on your heart and lungs. Treatment aims to reduce symptoms like shortness of breath and fatigue, improve your ability to do daily activities, and slow down how quickly the disease gets worse. Because PAH affects people differently, your treatment plan will depend on how advanced your condition is, what might be causing it, and how your body responds to different therapies.^[1][2]

Medical societies and expert groups have developed guidelines that help doctors choose the right treatments for each patient. These recommendations are based on years of research and clinical experience. At the same time, scientists continue to explore new ways to treat PAH through clinical trials. These studies test experimental drugs and innovative approaches that may one day become standard treatment options. Understanding both the established treatments and the emerging therapies can help you make informed decisions about your care.^[5][13]

It’s important to know that pulmonary hypertension cannot be cured, but treatments can significantly reduce symptoms and help you manage your condition. If the cause is identified and treated early, it may be possible to prevent permanent damage to the blood vessels in your lungs. Left untreated, PAH usually gets worse over time and may cause heart failure, which can be life-threatening. That’s why starting treatment as soon as possible is so important.^[6][14]

Standard Medications That Form the Foundation of PAH Treatment

The backbone of PAH treatment consists of medications that work to relax and widen the blood vessels in your lungs. These drugs help lower the pressure in your pulmonary arteries, making it easier for your heart to pump blood through them. Several different classes of medications are available, and they work through different mechanisms in your body.^[9][10]

Prostacyclin analogs and receptor agonists are among the most effective treatments for advanced PAH. The first drug specifically approved for pulmonary hypertension was epoprostenol (Flolan), which is delivered through a continuous intravenous infusion. This medication requires significant commitment from patients because it must be mixed daily, kept refrigerated, and delivered through a special catheter that requires meticulous care to prevent serious infections. Despite these challenges, studies have shown that Flolan can improve exercise capacity and survival in patients with advanced disease. Other drugs in this class include iloprost, which can be inhaled, and treprostinil, which offers more flexibility in how it’s delivered.^[10][15]

Common side effects of prostacyclins include headache, jaw discomfort, flushing, skin rashes, and stomach upset. While these symptoms can be bothersome, many patients find that they lessen over time or can be managed with adjustments to the dose. The benefits these medications provide often outweigh the inconvenience of side effects for people with severe PAH.^[15]

Endothelin receptor antagonists work by blocking the action of endothelin, a substance in your body that causes blood vessels to narrow. Medications in this class include bosentan, ambrisentan, and macitentan. These drugs are taken by mouth, which makes them more convenient than intravenous options. However, they require regular blood tests to monitor liver function because they can sometimes affect the liver. Your doctor will check your blood work periodically to make sure these medications are safe for you to continue taking.^[14][15]

Phosphodiesterase-5 inhibitors, including sildenafil and tadalafil, help relax blood vessels in the lungs by affecting a pathway involving a substance called cyclic GMP. These medications were originally developed for other conditions but have proven effective in treating PAH. They’re taken by mouth and generally well-tolerated, though some people experience headaches, flushing, or nasal congestion.^[14][15]

Soluble guanylate cyclase stimulators like riociguat work through a different mechanism to increase cyclic GMP levels, which helps blood vessels relax. This medication has shown benefits for certain types of pulmonary hypertension and may be an option if other treatments aren’t suitable for you.^[14]

Some patients with PAH may benefit from calcium channel blockers such as nifedipine, diltiazem, or amlodipine. However, these medications are only appropriate for a small subset of patients who respond positively to a special test during their diagnostic evaluation. Not everyone with PAH should take calcium channel blockers, and your doctor will determine if they’re right for you.^[14][15]

Supportive Therapies That Work Alongside Targeted Treatments

In addition to medications that specifically target the blood vessels in your lungs, several supportive therapies can help manage the effects of PAH on your body. Anticoagulant medicines like warfarin help prevent blood clots from forming. Because people with PAH have an increased risk of blood clots in their lungs, these medications can be an important part of treatment. If you take warfarin, you’ll need regular blood tests to make sure your dose is correct.^[6][14]

Diuretics, often called water tablets, help remove excess fluid from your body. As PAH progresses, the right side of your heart may struggle to pump effectively, leading to fluid buildup in your legs, ankles, or abdomen. Diuretics help relieve this swelling and reduce the strain on your heart. Your doctor may ask you to weigh yourself daily because sudden weight gain can signal fluid retention and may mean your treatment needs adjustment.^[6][14]

Digoxin is a medication that can strengthen your heart muscle contractions and slow down a fast heart rate. While not used as frequently as other treatments, it may be helpful for some patients, particularly those who also have heart rhythm problems.^[6]

Home oxygen therapy may be prescribed if the oxygen level in your blood is low. Breathing air with a higher concentration of oxygen helps ensure your body’s tissues get enough oxygen despite the reduced blood flow through your lungs. Some people need oxygen only during physical activity or sleep, while others benefit from using it throughout the day.^[6][14]

When Surgery or Procedures Become Necessary

For some people with pulmonary hypertension, medications alone may not be enough. Several surgical procedures and interventions can help in specific situations. A pulmonary endarterectomy is an operation to remove old blood clots from the pulmonary arteries in people with chronic thromboembolic pulmonary hypertension, a specific type of PH caused by blood clots. This surgery can dramatically improve symptoms and quality of life for carefully selected patients.^[14]

Balloon pulmonary angioplasty is a newer procedure where a tiny balloon is guided into the affected arteries and briefly inflated to push blockages aside and restore blood flow. This approach may be considered for patients who aren’t suitable candidates for pulmonary endarterectomy. Studies have shown it can lower blood pressure in the lung arteries, improve breathing, and increase the ability to exercise.^[14]

In severe cases where other treatments have failed, lung transplantation or heart-lung transplantation may be considered. These are major operations with significant risks, but they can be life-saving for patients with very advanced disease. Transplantation is rarely used today because effective medications are available, but it remains an option when other approaches haven’t worked.^[6][14]

Promising New Treatments Being Studied in Clinical Trials

While current medications have improved outcomes for many people with PAH, researchers continue to search for even better treatments. Clinical trials are research studies that test new drugs, combinations of existing medications, and innovative therapies to see if they’re safe and effective. Participating in a clinical trial gives patients access to cutting-edge treatments that aren’t yet available to the general public, and it helps advance medical knowledge that can benefit future patients.^[13]

Clinical trials typically progress through three phases. Phase I trials focus primarily on safety, testing the new treatment in a small group of people to see what side effects occur and determine the appropriate dose. Phase II trials involve more participants and aim to evaluate whether the treatment works and continues to be safe. Phase III trials compare the new treatment with the current standard of care in a large group of patients to definitively determine its effectiveness and monitor for side effects.^[5]

Gene Therapy: Targeting the Root Causes of Disease

Gene therapy represents one of the most innovative approaches being explored for PAH. This strategy involves delivering genetic material into cells to correct or compensate for abnormal genes that contribute to disease. Because some forms of PAH are linked to genetic mutations, researchers are investigating whether introducing healthy genes or modifying existing ones could slow or reverse the disease process. Early studies in laboratory models have shown promise, but gene therapy for PAH is still in the experimental stages and not yet available for routine clinical use.^[13]

Scientists are also exploring ways to use gene therapy to increase production of substances that help keep blood vessels relaxed and open. By delivering genes that encode beneficial proteins, researchers hope to create lasting improvements in pulmonary blood flow without the need for daily medications. While this approach is exciting, much more research is needed to ensure it’s safe and effective in humans.^[13]

Stem Cell Therapies: Harnessing the Body’s Repair Mechanisms

Stem cell-based therapies are another area of active investigation. Stem cells have the unique ability to develop into many different cell types and to release substances that promote healing and reduce inflammation. Researchers are studying whether stem cells could help repair damaged blood vessels in the lungs or reduce the harmful remodeling that occurs in PAH. Some early clinical trials have explored using stem cells derived from bone marrow or other sources, but this research is still in its early stages and considerable work remains before stem cell therapy could become a standard treatment for PAH.^[13]

Epigenetic Therapies: Changing How Genes Are Expressed

Epigenetic therapies work by changing how genes are turned on or off without actually altering the DNA sequence itself. In PAH, certain patterns of gene expression contribute to the narrowing and stiffening of blood vessels. Researchers are investigating drugs that can modify these patterns, potentially reversing some of the harmful changes that occur in the disease. This approach is particularly interesting because it might address multiple aspects of PAH simultaneously rather than targeting just one pathway.^[13]

Novel Molecules Targeting Specific Disease Pathways

Scientists continue to identify new molecular pathways involved in PAH, and each discovery opens the door to potential new treatments. Some experimental drugs in clinical trials work by targeting inflammation, which plays a role in damaging blood vessels. Others focus on preventing the excessive growth and multiplication of cells in the vessel walls, a process called proliferation that contributes to narrowing of the arteries.^[13]

One area of investigation involves drugs that target growth factors and their receptors. These are substances that normally help control cell growth and blood vessel formation, but in PAH they can contribute to harmful vessel remodeling. By blocking these pathways, researchers hope to slow or stop disease progression. Various experimental compounds with code names are being tested in different phases of clinical trials, though specific details about individual drugs would require information beyond what’s provided in the sources.^[13]

Clinical trials for PAH are conducted at medical centers around the world, including locations in the United States, Europe, and other regions. Eligibility for trials depends on many factors, including the type and severity of your PAH, what treatments you’ve already tried, and your overall health status. If you’re interested in participating in a clinical trial, talk to your healthcare provider. They can help you understand which trials might be appropriate for you and how to enroll.^[5]

Treating the Underlying Conditions That Cause PAH

If another medical condition is causing your pulmonary hypertension, treating that underlying problem is a crucial part of your overall treatment plan. When doctors can identify and address the root cause early, they may be able to prevent the pulmonary arteries from being permanently damaged.^[6][14]

For example, people whose PAH is related to connective tissue diseases like scleroderma or lupus will need treatment for those conditions in addition to PAH-specific medications. Those with PAH caused by HIV infection require antiretroviral therapy to control the virus. People with congenital heart defects may need surgical correction of the heart abnormality. Addressing these underlying conditions doesn’t always reverse the pulmonary hypertension, but it can prevent further worsening and improve overall health outcomes.^[2][11]

Managing underlying conditions often requires working with multiple specialists. Your healthcare team might include a pulmonary hypertension specialist, a cardiologist, a rheumatologist (for autoimmune diseases), an infectious disease specialist (for HIV), or other experts depending on your specific situation. Good communication among all your doctors helps ensure you receive coordinated care that addresses all aspects of your health.^[12]

Most common treatment methods

• Prostacyclin analogs and receptor agonists
  • Epoprostenol (Flolan) delivered through continuous intravenous infusion, requiring daily mixing and refrigeration
  • Improves exercise capacity and survival in advanced PAH patients
  • Other options include iloprost (inhaled) and treprostinil (multiple delivery methods)
  • Common side effects: headache, jaw discomfort, flushing, rashes, stomach upset
• Endothelin receptor antagonists
  • Medications include bosentan, ambrisentan, and macitentan
  • Taken by mouth for convenience
  • Block the action of endothelin, a substance that narrows blood vessels
  • Require periodic blood tests to monitor liver function
• Phosphodiesterase-5 inhibitors
  • Include sildenafil and tadalafil
  • Help relax blood vessels through cyclic GMP pathway
  • Taken orally and generally well-tolerated
  • May cause headaches, flushing, or nasal congestion
• Supportive medications
  • Anticoagulants like warfarin to prevent blood clots
  • Diuretics to remove excess fluid and reduce swelling
  • Digoxin to strengthen heart contractions and control heart rate
  • Home oxygen therapy for low blood oxygen levels
• Surgical procedures
  • Pulmonary endarterectomy to remove blood clots in chronic thromboembolic pulmonary hypertension
  • Balloon pulmonary angioplasty to open blocked arteries
  • Lung or heart-lung transplantation for severe, treatment-resistant cases
• Experimental therapies in clinical trials
  • Gene therapy to correct genetic mutations or deliver beneficial genes
  • Stem cell therapies to repair damaged blood vessels and reduce inflammation
  • Epigenetic therapies to modify gene expression patterns
  • Novel drugs targeting inflammation, proliferation, and growth factor pathways